Cargando…
Glucocorticoid Receptor (GR) antagonism as disease-modifying treatment for MDD with childhood trauma: protocol of the RESET-medication randomized controlled trial
BACKGROUND: Major depressive disorder (MDD) is a heterogeneous psychiatric disorder. Childhood trauma (CT, emotional/physical/sexual abuse or neglect before the age of 18) is one of the largest and most consistent risk factors for development and poor course of MDD. Overactivity of the HPA-axis and...
Autores principales: | Linsen, F., Broeder, C., Sep, M. S. C., Verhoeven, J. E., Bet, P. M., Penninx, B. W. J. H., Meijer, O. C., Vinkers, C. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173560/ https://www.ncbi.nlm.nih.gov/pubmed/37170109 http://dx.doi.org/10.1186/s12888-023-04830-9 |
Ejemplares similares
-
Design and rationale of the REStoring mood after early life trauma with psychotherapy (RESET-psychotherapy) study: a multicenter randomized controlled trial on the efficacy of adjunctive trauma-focused therapy (TFT) versus treatment as usual (TAU) for adult patients with major depressive disorder (MDD) and childhood trauma
por: Gathier, Anouk W., et al.
Publicado: (2023) -
Glucocorticoid receptor GRβ regulates glucocorticoid-induced ocular hypertension in mice
por: Patel, Gaurang C., et al.
Publicado: (2018) -
Efficacy of celecoxib add-on treatment for immuno-metabolic depression: Protocol of the INFLAMED double-blind placebo-controlled randomized controlled trial
por: Zwiep, J.C., et al.
Publicado: (2022) -
Peripheral glucocorticoid receptor antagonism by relacorilant with modest HPA axis disinhibition
por: Viho, Eva M G, et al.
Publicado: (2022) -
The neurocognitive profile of post‐traumatic stress disorder (PTSD), major depressive disorder (MDD), and PTSD with comorbid MDD
por: Koopowitz, Sheri‐Michelle, et al.
Publicado: (2021)